Adaptive Biotechnologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
ADPT Key Statistics
Stock Snapshot
With a market cap of 2.24B, Adaptive Biotechnologies(ADPT) trades at $14.68. The stock has a price-to-earnings ratio of -28.92.
During the trading session on 2025-11-07, Adaptive Biotechnologies(ADPT) shares reached a daily high of $15.80 and a low of $14.53. At a current price of $14.68, the stock is +1.0% higher than the low and still -7.1% under the high.
Trading volume for Adaptive Biotechnologies(ADPT) stock has reached 1.04M, versus its average volume of 1.55M.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $17.89 and a low of $4.27.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $17.89 and a low of $4.27.
ADPT News
Earnings Call Insights Adaptive Biotechnologies outlines 39%–42% MRD revenue growth outlook for 2025 with accelerating EMR integration Nov. 06, 2025 7:57 AM ET...
Adaptive Biotechnologies ( (ADPT) ) has released its Q3 earnings. Here is a breakdown of the information Adaptive Biotechnologies presented to its investors. El...
In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Adaptive Biotechnologies, with a price target of $22.00. Meet Your ETF AI An...
Analyst ratings
88%
of 8 ratingsMore ADPT News
Reports Q3 revenue $93.97M, consensus $64.65M. “Our third quarter results reflect another period of strong growth and financial progress,” said Chad Robins, chi...
In recent trading, shares of Adaptive Biotechnologies Corp (Symbol: ADPT) have crossed above the average analyst 12-month target price of $9.86, changing hands...
